Tropheryma whipplei

Background

Microbiology

• Fastidious Gram-positive bacillus

Epidemiology

• Ubiquitous environmental organism, but rarely causes disease with only about 12 new cases diagnosed annually worldwide
  • Can be found in saliva of one third of healthy people
• Disease is more common in white European (98%) males (85%)
• Farming or occupational soil/animal exposures are commone

Pathophysiology

• Lack of host immune response

Clinical Manifestations

Classic Whipple's Disease

• Cardinal features include: arthralgias, followed by weight loss, diarrhea, and abdominal pain
• Arthralgias are typically migratory in the larger peripheral joints, including knees, ankles, and wrists, but can have essentially any presentation
  • May be present for years before development of other symptoms
• The diarrhea is intermittent, with colicky abdominal pain
  • Diarrhea can be watery or have steatorrhea
  • Occasional GI bleeding

Other Symptoms

• Fever in 25 to 40%
• Lymphadenopathy, mostly of mesenteric and mediastinal nodes
• CNS disease
  • Dementia, supranuclear ophthalmoplegia, nystagmus, and myoclonus
  • Oculomasticatory myorhythmia and oculo-facial-skeletal myorhythmia with a supranuclear vertical gaze palsy
  • Cerebellar ataxia
  • Symptoms can occur with disease or as a post-treatment relapse
• Cardiac disease
  • Culture-negative endocarditis, pericarditis, and myocarditis
  • Endocarditis may occur on its own without other features of disease
• Skin hyperpigmentation in 40%
• Pleural effusion, chronic cough, interstitial lung disease, pulmonary hypertension
• Anemia in 80%, leukocytosis in 50%, thrombocytosis in 50%
• Elevated C-reactive protein in 70%

Diagnosis

• Samples should be taken from involved sites, with a strong preference for small bowel biopsy if there are GI symptoms, but also synovial or cerebrospinal fluid or heart valve
  • Up to 7 to 10 biopsies from small bowel, ideally
• Diagnosis is based on:
  • Periodic acid-Schiff-positive bacilli in macrophages
  • PCR
  • Immunohistochemistry

Management

• Generally treat with parenteral ceftriaxone 2 g IV daily or penicillin 2 MU IV q4h for 2 weeks followed by TMP-SMX DS PO bid for 1 year
  • Treatment can precipitate a Jarisch-Herxheimer reaction
  • May also see immune reconstitution inflammatory syndrome in early treatment
• Other options include meropenem, doxycycline, macrolides, ketolides, aminoglycosides, rifampin, teicoplanin, and chloramphenicol
• Consider repeating small bowel biopsies annually for a few years

Prognosis

• Clinical improvement takes 1 to 3 weeks of treatment
• Neurologic sequelae may be permanent
• Relapses after treatment, including of CNS disease, can happen in up to a third of patients